Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
347 EUR | -0.57% | -2.80% | -3.48% |
Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated | |
Apr. 17 | Virbac: sales up by almost 10% in Q1 | CF |
Sales 2024 * | 1.38B 1.47B | Sales 2025 * | 1.48B 1.58B | Capitalization | 2.9B 3.1B |
---|---|---|---|---|---|
Net income 2024 * | 139M 148M | Net income 2025 * | 155M 165M | EV / Sales 2024 * | 2.16 x |
Net Debt 2024 * | 73.54M 78.38M | Net cash position 2025 * | 44M 46.9M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
18.9
x | Employees | 5,459 |
Yield 2024 * |
0.42% | Yield 2025 * |
0.47% | Free-Float | 49.58% |
Latest transcript on Virbac
1 day | -0.57% | ||
1 week | -2.80% | ||
Current month | +0.29% | ||
1 month | +0.29% | ||
3 months | +3.89% | ||
6 months | +28.52% | ||
Current year | -3.48% |
Managers | Title | Age | Since |
---|---|---|---|
Sébastien Huron
CEO | Chief Executive Officer | 54 | 05-12-31 |
Habib Ramdani
DFI | Director of Finance/CFO | 48 | 16-01-31 |
Sophie Favini
COO | Chief Operating Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 10-12-31 | |
Philippe Capron
BRD | Director/Board Member | 65 | 03-12-31 |
Chairman | 59 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 1 M€ | -.--% | ||
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 347 | -0.57% | 2,225 |
24-04-29 | 349 | -.--% | 2,972 |
24-04-26 | 349 | +0.72% | 7,198 |
24-04-25 | 346.5 | -3.75% | 5,641 |
24-04-24 | 360 | +0.28% | 1,844 |
Real-time Euronext Paris, April 30, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.48% | 3.13B | |
-19.32% | 72.97B | |
-11.68% | 6.69B | |
+2.36% | 1.44B | |
-15.13% | 1.34B | |
-7.91% | 1.25B | |
-25.63% | 1.24B | |
-10.84% | 1.15B | |
-.--% | 1.01B | |
-23.05% | 817M |
- Stock Market
- Equities
- VIRP Stock